Infectious Complications Reporting in Common Variable Immunodeficiency: A Systematic Review and Meta-Analysis Publisher



Zainaldain H¹ ; Rizvi FS¹ ; Rafiemanesh H² ; Alizadeh M^{3, 4} ; Jamee M^{3, 4} ; Mohammadi S¹ ; Kiaee F⁵ ; Mohammadi H⁶ ; Babaie F⁷ ; Yazdani R¹ ; Abolhassani H⁸ ; Aghamohammadi A¹ ; Azizi G⁴ Show Affiliations
Source: Oman Medical Journal Published:2020

Abstract

Objectives: Common variable immunodeficiency (CVID) is a heterogeneous disorder characterized by hypogammaglobulinemia and increased susceptibility to recurrent infections. Methods: We searched PubMed, Web of Science, and Scopus databases to find eligible studies from the earliest available date to January 2018 with standard keywords. Pooled estimates of the infection prevalence and the corresponding 95% confidence intervals were calculated using random-effects models. Results: We found that pneumonia (67.7%) was the most prevalent infection followed by upper respiratory tract (59.0%) and gastrointestinal infections (36.3%). Furthermore, bacterial complications (41.7%) were higher in CVID patients compared to viral (25.4%), parasitic (18.8%), or fungal (3.4%) infections. Patients with longer age at diagnosis presented with fewer disease comorbidities. There was an inverse correlation between T lymphocyte count and viral infections. Moreover, we found that immunoglobulin M (IgM) serum level was inversely correlated with hepatitis C and gastrointestinal infections, and IgG serum level was inversely correlated with infectious arthritis. Higher numbers of CD4 and CD8 T cells were associated with the lower frequencies of otitis media. CVID patients with infections had significantly lower percentages of CD3 T cells. In contrast, higher percentages of CD19 lymphocytes were found in CVID patients who had a history of infections. Conclusions: Our findings demonstrated that in addition to hypogammaglobulinemia, patients with CVID have an imbalance in the frequency of T lymphocytes, which is in parallel with the higher frequency of infectious complications. © 2020, Oman Medical Specialty Board. All rights reserved.